These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 3101337
1. Failure to induce puberty in a man with X-linked congenital adrenal hypoplasia and hypogonadotropic hypogonadism by pulsatile administration of low-dose gonadotropin-releasing hormone. Kikuchi K, Kaji M, Momoi T, Mikawa H, Shigematsu Y, Sudo M. Acta Endocrinol (Copenh); 1987 Jan; 114(1):153-60. PubMed ID: 3101337 [Abstract] [Full Text] [Related]
2. Contrasting effects of subcutaneous pulsatile GnRH therapy in congenital adrenal hypoplasia and Kallmann's syndrome. Gordon D, Cohen HN, Beastall GH, Hay ID, Thomson JA. Clin Endocrinol (Oxf); 1984 Dec; 21(6):597-603. PubMed ID: 6439437 [Abstract] [Full Text] [Related]
12. Pulsatile gonadotropin-releasing hormone therapy in male patients with Kallmann's syndrome or constitutional delay of puberty. Happ J, Ditscheid W, Krause U. Fertil Steril; 1985 Apr; 43(4):599-608. PubMed ID: 3921412 [Abstract] [Full Text] [Related]
13. Bioactive follicle-stimulating hormone responses to intravenous gonadotropin-releasing hormone in boys with idiopathic hypogonadotropic hypogonadism. Padmanabhan V, Kelch RP, Sonstein J, Foster CM, Beitins IZ. J Clin Endocrinol Metab; 1988 Oct; 67(4):793-800. PubMed ID: 3138278 [Abstract] [Full Text] [Related]
14. Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone. Hoffman AR, Crowley WF. N Engl J Med; 1982 Nov 11; 307(20):1237-41. PubMed ID: 6813732 [Abstract] [Full Text] [Related]
15. Non-responsiveness of serum gonadotropins and testosterone to pulsatile GnRH in hemochromatosis suggesting a pituitary defect. Duranteau L, Chanson P, Blumberg-Tick J, Thomas G, Brailly S, Lubetzki J, Schaison G, Bouchard P. Acta Endocrinol (Copenh); 1993 Apr 11; 128(4):351-4. PubMed ID: 8498154 [Abstract] [Full Text] [Related]
16. Testosterone administration inhibits gonadotropin secretion by an effect directly on the human pituitary. Sheckter CB, Matsumoto AM, Bremner WJ. J Clin Endocrinol Metab; 1989 Feb 11; 68(2):397-401. PubMed ID: 2493030 [Abstract] [Full Text] [Related]
17. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH. Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, Flamigni C. J Clin Endocrinol Metab; 1988 Feb 11; 66(2):327-33. PubMed ID: 3123511 [Abstract] [Full Text] [Related]
18. Effect of thyrotropin-releasing hormone and gonadotropin-releasing hormone on serum TSH, PRL, hGH, FSH and LH in primary testicular failure and in hypogonadotrophic hypogonadism. Szilágyi G, Szabolcs I, Vydra G, Góth M, Irsy G. Acta Med Hung; 1984 Feb 11; 41(4):175-83. PubMed ID: 6440114 [Abstract] [Full Text] [Related]
19. Events surrounding the initiation of puberty with long term subcutaneous pulsatile gonadotropin-releasing hormone in a female patient with Kallman's syndrome. Seibel MM, Claman P, Oskowitz SP, McArdle C, Weinstein FG. J Clin Endocrinol Metab; 1985 Sep 11; 61(3):575-9. PubMed ID: 3926811 [Abstract] [Full Text] [Related]
20. Exaggerated free alpha-subunit levels during pulsatile gonadotropin-releasing hormone replacement in women with idiopathic hypogonadotropic hypogonadism. Lavoie HB, Martin KA, Taylor E, Crowley WF, Hall JE. J Clin Endocrinol Metab; 1998 Jan 11; 83(1):241-7. PubMed ID: 9435449 [Abstract] [Full Text] [Related] Page: [Next] [New Search]